We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

News · December 20, 2021

21-Gene Assay Guides Chemotherapy in Node-Positive Breast Cancer

Recurrence score of 25 or lower predicts benefit of adjuvant chemo for premenopausal, but not postmenopausal, women with N1 breast cancer



Further Reading